Legend Biotech's stock reflects demand for innovative CAR-T cancer therapies. The US biotech focuses on commercializing Carvykti with partner Janssen while expanding its pipeline. Approved revenue...
Multiply Labs has secured its first major collaboration with Legend Biotech to use robotic technology in cell therapy manufacturing. The partnership aims to improve efficiency and...